Search Results

You searched for : DrreddysNews

	Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG 2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ... Jun 28
	Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG 2-DG is yet another addition to our COVID-19 portfolio that already covers the full spectrum of mild to moderate and severe conditions and ... Jun 28
	Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market Dr. Reddyâ€™s Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120â€™s count.... Jun 22
	Dr. Reddy's, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS Tablets ... Dec 22
	Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study.... Dec 02
	Reddy's partners with Department of Biotechnology for Sputnik V vaccine clinical trials in India ... Oct 29
	Dr. Reddyâ€™s announces the re-launch of OTC Famotidine Tablets USP, store-brand equivalent of Pepcid AC in the U.S. Market ... Oct 20
	Dr. Reddyâ€™s Laboratories joins Science Based Targets initiative and sets 2030 GHG emission targets Dr. Reddyâ€™s Laboratories Ltd. has joined the SBTi becoming the first Indian and the third Asian pharma company to further minimize environmental impact... Oct 05
	Dr. Reddy's announces launch of a generic version of Sapropterin Dihydrochloride Tablets in the U.S. Market Dr. Reddyâ€™s Laboratories Ltd. today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. ... Oct 03
	Dr. Reddy's announces launch of a generic version of Sapropterin Dihydrochloride Tablets in the U.S. Market Dr. Reddyâ€™s Laboratories Ltd. today announced the launch of a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. ... Oct 03
	Dr. Reddy's Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market Dr. Reddyâ€™s Laboratories Ltd., today announced the launch of Cinacalcet Tablets, a generic version of Sensipar Tablets, approved by the USFDA... Oct 01
	Dr. Reddy's announces launch of Dexmedetomidine Hydrochloride in the U.S. Market ... Sep 25
12 Matching result(s) found!

-Advertisements-

Trending Now
	Cancer on the Menu: How Excess Salt is Quietly Killing Your StomachDecember 03, 2024
	Breaking Barriers: Honouring the International Day of Persons with Disabilities December 03, 2024
	Invisible Threat: How Air Pollution is Impacting Pregnancies and Shaping Future GenerationsDecember 03, 2024
	Medanta Gurugram successfully treats ‘rarest of rare’ lymph node cancer resistant to other drugs using CAR-T Cell TherapyDecember 03, 2024
	Nonin Medical secures FDA clearance for its over-the-counter fingertip pulse oximeter, accurate for patients of all skin colorsDecember 02, 2024
	ALARM 2024: Amrita Leads the Fight Against Antimicrobial ResistanceDecember 02, 2024
	Coral adaptation unlikely to keep pace with global warmingDecember 02, 2024
	Reaching the unreached to find missing TB casesDecember 02, 2024
	Sip Smart: Why Changing Your Water Habits Can Change Your LifeNovember 28, 2024
	Can Your Fingers Predict How Much You Drink? New Study ExplainsNovember 28, 2024
	India Leads Global Medical Tourism with 8% Share; PSRI Sets New Benchmarks with nearly 15% International Patient BaseNovember 28, 2024
	Medicines save lives but not when they stop workingNovember 28, 2024
	A total of 340 Children Participated in the Painting Competition Organized by Asian HospitalNovember 28, 2024
	The Standing Desk Myth: Is Sitting Actually Healthier?November 27, 2024
	How Cancer Outsmarts Chemotherapy: The Hidden Metabolic GameNovember 27, 2024
	Aakash Healthcare Saves life of a 61-year-old Women through Timely Neuro-intervention with a multi-disciplinary management of StrokeNovember 27, 2024
	Breakfast Wars: Why Men and Women Should Eat DifferentlyNovember 27, 2024
	Only 10% of Businesses Are Ready to Become Experience-Orchestrated, Highlighting Lack of PersonalisationNovember 27, 2024
	Investors Think Safe, but Act Bold: MyFi Report Exposes Risk Tolerance Mismatch November 27, 2024
	Indkal Technologies Redefines Luxury Home Entertainment with Acer M Series Hybrid MiniLED TelevisionsNovember 27, 2024

Search Results

Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG

Dr. Reddyâ€™s Laboratories Announces Commercial Launch of 2DG

Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market

Dr. Reddy's, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS Tablets

Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India

Reddy's partners with Department of Biotechnology for Sputnik V vaccine clinical trials in India

Dr. Reddyâ€™s announces the re-launch of OTC Famotidine Tablets USP, store-brand equivalent of Pepcid AC in the U.S. Market

Dr. Reddyâ€™s Laboratories joins Science Based Targets initiative and sets 2030 GHG emission targets

Dr. Reddy's announces launch of a generic version of Sapropterin Dihydrochloride Tablets in the U.S. Market

Dr. Reddy's announces launch of a generic version of Sapropterin Dihydrochloride Tablets in the U.S. Market

Dr. Reddy's Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market

Dr. Reddy's announces launch of Dexmedetomidine Hydrochloride in the U.S. Market

Trending Now